Benjamin Roa
Overview
Explore the profile of Benjamin Roa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
499
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hughes E, Wagner S, Pruss D, Bernhisel R, Probst B, Abkevich V, et al.
JCO Precis Oncol
. 2022 Nov;
6:e2200084.
PMID: 36331239
Purpose: Polygenic risk scores (PRSs) for breast cancer (BC) risk stratification have been developed primarily in women of European ancestry. Their application to women of non-European ancestry has lagged because...
2.
Nix P, Mundt E, Manley S, Coffee B, Roa B
JCO Precis Oncol
. 2022 Jan;
4:1224-1225.
PMID: 35050779
No abstract available.
3.
Nix P, Mundt E, Manley S, Coffee B, Roa B
JCO Precis Oncol
. 2022 Jan;
4:730-735.
PMID: 35050751
No abstract available.
4.
Gallagher S, Hughes E, Kurian A, Domchek S, Garber J, Probst B, et al.
JCO Precis Oncol
. 2021 Jul;
5.
PMID: 34322652
Purpose: Breast cancer risks for and pathogenic variant (PV) carriers are modified by an 86-single nucleotide polymorphism polygenic risk score (PRS) and individual clinical factors. Here, we describe comprehensive risk...
5.
Hughes E, Tshiaba P, Wagner S, Judkins T, Rosenthal E, Roa B, et al.
JCO Precis Oncol
. 2021 May;
5.
PMID: 34036224
Purpose: Screening and prevention decisions for women at increased risk of developing breast cancer depend on genetic and clinical factors to estimate risk and select appropriate interventions. Integration of polygenic...
6.
Nix P, Mundt E, Coffee B, Goossen E, Warf B, Brown K, et al.
Fam Cancer
. 2021 Jan;
21(1):7-19.
PMID: 33469799
A substantial proportion of pathogenic variants associated with an increased risk of hereditary cancer are sequence variants affecting RNA splicing. The classification of these variants can be complex when both...
7.
Hughes E, Tshiaba P, Gallagher S, Wagner S, Judkins T, Roa B, et al.
JCO Precis Oncol
. 2020 Sep;
4.
PMID: 32923876
Purpose: Women with a family history of breast cancer are frequently referred for hereditary cancer genetic testing, yet < 10% are found to have pathogenic variants in known breast cancer...
8.
Warf M, Fosso P, Hughes E, Perry M, Brown K, Reid J, et al.
Biomark Med
. 2015 Jul;
9(9):901-10.
PMID: 26158298
Aims: The aim of these studies was to validate the analytical performance of a cell cycle progression (CCP) gene signature that provides prognostic information for early stage lung adenocarcinomas. Materials...
9.
Judkins T, Leclair B, Bowles K, Gutin N, Trost J, McCulloch J, et al.
BMC Cancer
. 2015 Apr;
15:215.
PMID: 25886519
Background: Germline DNA mutations that increase the susceptibility of a patient to certain cancers have been identified in various genes, and patients can be screened for mutations in these genes...
10.
Clarke L, Warf M, Flake 2nd D, Hartman A, Tahan S, Shea C, et al.
J Cutan Pathol
. 2015 Mar;
42(4):244-52.
PMID: 25727210
Background: Histopathologic examination is sometimes inadequate for accurate and reproducible diagnosis of certain melanocytic neoplasms. As a result, more sophisticated and objective methods have been sought. The goal of this...